January 4, 2017 / 2:52 PM / a year ago

BRIEF-Roche launches Cobas c 513 analyzer and HbA1c Gen. 3 assay

Jan 4 (Reuters) - Roche Holding Ag

* Roche launches Cobas c 513 analyzer and HbA1c Gen. 3 assay to meet increasing demand for testing of people with diabetes

* hba1c testing solution, cobas c 513 analyzer, and hba1c gen. 3 assay has received 510(k) clearance from U.S. FDA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below